147 related articles for article (PubMed ID: 15053783)
21. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Ghali JK; Wikstrand J; Van Veldhuisen DJ; Fagerberg B; Goldstein S; Hjalmarson A; Johansson P; Kjekshus J; Ohlsson L; Samuelsson O; Waagstein F; Wedel H;
J Card Fail; 2009 May; 15(4):310-8. PubMed ID: 19398079
[TBL] [Abstract][Full Text] [Related]
22. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
[TBL] [Abstract][Full Text] [Related]
23. The function of left ventricular basal segments is most important for long-term recovery.
Scharin Täng M; Waagstein F; Andersson B
Int J Cardiol; 2007 Oct; 121(3):284-90. PubMed ID: 17257693
[TBL] [Abstract][Full Text] [Related]
24. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
[TBL] [Abstract][Full Text] [Related]
25. [Effect of beta-blockers metoprolol CR/XL and carvedilol on left ventricular contractility in patients with chronic low cardiac output].
Syrkin AL; Kukes VG; Poltavskaia MG; Andreev DA; Aref'eva AB; Teplonogova EV; Konova IA; Rykova MS
Ter Arkh; 2003; 75(9):73-7. PubMed ID: 14582439
[TBL] [Abstract][Full Text] [Related]
26. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Ghali JK; Dunselman P; Waagstein F; Goldstein S; Gottlieb SS; Deedwania PC; Wikstrand JC
J Card Fail; 2004 Dec; 10(6):452-9. PubMed ID: 15599834
[TBL] [Abstract][Full Text] [Related]
27. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
Gottlieb SS; Fisher ML; Kjekshus J; Deedwania P; Gullestad L; Vitovec J; Wikstrand J;
Circulation; 2002 Mar; 105(10):1182-8. PubMed ID: 11889011
[TBL] [Abstract][Full Text] [Related]
28. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
[TBL] [Abstract][Full Text] [Related]
29. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
Clements IP; Miller WL
Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
[TBL] [Abstract][Full Text] [Related]
30. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).
Goldstein S; Deedwania P; Gottlieb S; Wikstrand J;
Am J Cardiol; 2003 Aug; 92(4):478-80. PubMed ID: 12914886
[TBL] [Abstract][Full Text] [Related]
31. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
[TBL] [Abstract][Full Text] [Related]
32. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
Gullestad L; Manhenke C; Aarsland T; Skårdal R; Fagertun H; Wikstrand J; Kjekshus J
Eur J Heart Fail; 2001 Aug; 3(4):463-8. PubMed ID: 11511433
[TBL] [Abstract][Full Text] [Related]
33. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
Groenning BA; Nilsson JC; Hildebrandt PR; Kjaer A; Fritz-Hansen T; Larsson HB; Sondergaard L
Eur J Heart Fail; 2002 Oct; 4(5):635-46. PubMed ID: 12413508
[TBL] [Abstract][Full Text] [Related]
34. [Heart failure with preserved left ventricular function: clinical, echocardiographic, and clinical course features. Prognostic factors].
Bounhoure JP; Massabuau P; Galinier M; Jordan C; Laurent JP; Marco J
Bull Acad Natl Med; 2002; 186(6):1003-13; discussion 1013-4. PubMed ID: 12587339
[TBL] [Abstract][Full Text] [Related]
35. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
[TBL] [Abstract][Full Text] [Related]
36. The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial.
Goldstein S; Hjalmarson A
Clin Cardiol; 1999 Oct; 22 Suppl 5():V30-5. PubMed ID: 10526701
[TBL] [Abstract][Full Text] [Related]
37. Effects of metoprolol in chagasic patients with severe congestive heart failure.
Dávila DF; Angel F; Arata de Bellabarba G; Donis JH
Int J Cardiol; 2002 Oct; 85(2-3):255-60. PubMed ID: 12208592
[TBL] [Abstract][Full Text] [Related]
38. Pronounced improvement in systolic and diastolic ventricular long axis function after treatment with metoprolol.
Grüner Sveälv B; Täng MS; Waagstein F; Andersson B
Eur J Heart Fail; 2007; 9(6-7):678-83. PubMed ID: 17448723
[TBL] [Abstract][Full Text] [Related]
39. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis.
Erbay AR; Turhan H; Yasar AS; Bicer A; Senen K; Sasmaz H; Sabah I; Yetkin E
Int J Cardiol; 2005 Jun; 102(1):33-7. PubMed ID: 15939096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
